Skip to main content

Susan K. Langer

Equibles does not estimate personal net worth.

About Susan K. Langer

Susan K. Langer is recorded as Board Member at Biogen Inc. (BIIB) since January 1, 2023. The newest filing on record that lists Susan K. Langer as Board Member at Biogen Inc. (BIIB) is dated April 28, 2026. Biogen Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Biogen Inc. includes Christopher A. Viehbacher (CEO and Board Member), Caroline D. Dorsa (Chairman), Michael R. McDonnell (CFO) and 7 others.

Affiliation history

  • Biogen Inc. (BIIB)

    Board Member

    Proxy statement

    Current

    2023-01-01–present

    Last confirmed April 28, 2026

Company network

Current role

Drug Manufacturers - General · Healthcare

Board Member

2023-01-01–present

Leadership on record at Biogen Inc.

Recent activity

No call appearances or filed executive changes recorded yet.